RAB3B, up-regulated in prostate cancer through AR [33], was the top-most jointly differentially expressed gene in this subgroup, with reduced expression relative to either NEPCs or adenocarcinomas (Additional file 3: Figure S4). The gene discussed is RAB3B; the disease is adenocarcinoma.